What is a stock summary page? Click here for an overview.
Business Description
Rezolute Inc
NAICS : 325412
SIC : 2834
ISIN : US76200L1017
Description
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 49.97 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 20 | |||||
| 3-Year EPS without NRI Growth Rate | 24.4 | |||||
| 3-Year FCF Growth Rate | 25.2 | |||||
| 3-Year Book Growth Rate | -10.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.82 | |||||
| 9-Day RSI | 18.02 | |||||
| 14-Day RSI | 24.29 | |||||
| 3-1 Month Momentum % | 3.19 | |||||
| 6-1 Month Momentum % | -10.83 | |||||
| 12-1 Month Momentum % | 135.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | |||||
| Quick Ratio | 9.3 | |||||
| Cash Ratio | 9.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -85.4 | |||||
| Shareholder Yield % | -3.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -71.62 | |||||
| ROA % | -63.74 | |||||
| ROIC % | -644.76 | |||||
| 3-Year ROIIC % | -872.58 | |||||
| ROC (Joel Greenblatt) % | -3703.84 | |||||
| ROCE % | -71.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.85 | |||||
| Price-to-Tangible-Book | 1.84 | |||||
| EV-to-EBIT | -1.26 | |||||
| EV-to-Forward-EBIT | -2.91 | |||||
| EV-to-EBITDA | -1.26 | |||||
| EV-to-Forward-Revenue | 0.1 | |||||
| EV-to-FCF | -1.46 | |||||
| Price-to-Net-Current-Asset-Value | 2.12 | |||||
| Price-to-Net-Cash | 2.18 | |||||
| Earnings Yield (Greenblatt) % | -79.37 | |||||
| FCF Yield % | -34.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RZLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rezolute Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.22 | ||
| Beta | 0.07 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 0.95 | ||
| Volatility % | 73.31 | ||
| 14-Day RSI | 24.29 | ||
| 14-Day ATR ($) | 0.263299 | ||
| 20-Day SMA ($) | 3.804 | ||
| 12-1 Month Momentum % | 135.94 | ||
| 52-Week Range ($) | 1.885 - 6.1856 | ||
| Shares Outstanding (Mil) | 60.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rezolute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rezolute Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rezolute Inc Frequently Asked Questions
What is Rezolute Inc(RZLT)'s stock price today?
The current price of RZLT is $3.03. The 52 week high of RZLT is $6.19 and 52 week low is $1.89.
When is next earnings date of Rezolute Inc(RZLT)?
The next earnings date of Rezolute Inc(RZLT) is 2025-05-15 Est..
Does Rezolute Inc(RZLT) pay dividends? If so, how much?
Rezolute Inc(RZLT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers